Quest Laboratories IPO Details: Quest Laboratories is gearing up for its IPO, scheduled to kick off on May 15th and wrap up on May 17th. This marks a significant milestone for the company as it aims to raise ₹43.16 crores through this IPO, making its debut on the NSE SME platform. Investors will have the opportunity to participate within a price band of ₹93 to ₹97 per share, with a market lot set at 1200 shares.
At the core of Quest Laboratories is its dedication to crafting pharmaceutical formulations that cater to diverse medical needs. From antibiotics to antidepressants, their portfolio encompasses a wide range of essential medications, all branded under the name “Quest Laboratories Limited”. Their offerings span ethical drugs, generic medications, and over-the-counter remedies, available in various forms including tablets, liquids, powders, and ointments, ensuring accessibility for patients with different preferences.
What sets Quest Laboratories apart is its unwavering commitment to quality and compliance. Holding coveted certifications like WHO Schedule M GMP and GLP, the company operates under stringent guidelines mandated by the World Health Organization. With manufacturing consolidated under one roof, rigorous quality checks are implemented at every stage to guarantee that only products meeting the highest standards make it to the market.
Furthermore, Quest Laboratories boasts a Good Laboratory Practice (GLP) certificate from the Food & Drug Administration, Bhopal, Madhya Pradesh, underscoring its dedication to excellence in laboratory operations. Equipped with cutting-edge instruments like HPLC, GC, FTIR, UV, and Dissolution apparatus, their in-house laboratory facilitates a comprehensive range of tests and analyses, ensuring accuracy and efficiency in product evaluation.
Table of Contents
ToggleQuest Laboratories IPO Objectives:
The company proposes to utilize the Net Proceeds from the Issue towards funding the following objects:
- Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility;
- Funding working capital requirements of the company;
- General corporate purposes;
Quest Laboratories IPO Review (Apply or Not)
- Update Soon
Quest Laboratories IPO Date & Price Band Details:
IPO Open: | 15-May-2024 |
IPO Close: | 17-May-2024 |
IPO Size: | Approx ₹43.16 Crores, 4,449,600 Equity Shares |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹93 to ₹97 Per Equity Share |
IPO Listing on: | NSE SME |
Retail Quota: | 35% of the net offer |
QIB Quota: | 50% of the net offer |
NII Quota: | 15% of the net offer |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors in IPO: | Click Here |
Quest Laboratories IPO Lot Size:
Investors looking to participate in the Quest Laboratories IPO will need to consider the minimum market lot requirement, which stands at 1200 shares. This means that to get in on the action, one must be prepared to commit to this quantity of shares. With the minimum market lot set, the application amount required totals ₹116,400. This ensures that those entering the IPO are making a significant investment in the company’s future. It’s an opportunity for investors to engage with Quest Laboratories and potentially reap the benefits of its growth trajectory.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1200 | ₹116,400 |
Retail Maximum | 1 | 1200 | ₹116,400 |
S-HNI Minimum | 2 | 2400 | ₹232,800 |
Quest Laboratories IPO Timeline:
The much-anticipated Quest Laboratories IPO is scheduled to kick off on May 15th, with the window closing on May 17th. Investors eager to get in on the action can mark their calendars for the IPO allotment date set for May 21st. If all goes according to plan, we might witness the company making its debut on the stock exchange as early as May 23rd. It’s an exciting time for both the company and potential investors as they gear up for this significant event in the financial market.
IPO Open Date: | 15-May-2024 |
IPO Close Date: | 17-May-2024 |
Basis of Allotment: | 21-May-2024 |
Refunds: | 22-May-2024 |
Credit to Demat Account: | 22-May-2024 |
IPO Listing Date: | 23-May-2024 |
Quest Laboratories IPO GMP Today:
At present, the GMP (Grey Market Premium) for the Quest Laboratories SME IPO hasn’t commenced. However, we’re diligently monitoring the situation and updating the GMP information daily. We encourage you to check back with us regularly for the most up-to-date GMP updates. Your interest and patience are highly appreciated as we work to provide you with accurate information regarding this IPO.
Quest Laboratories Company Financial Report
₹ in Crores | |||
Year | Revenue | Expense | PAT |
2021 | ₹30.44 | ₹29.65 | ₹0.66 |
2022 | ₹59.54 | ₹53.78 | ₹4.11 |
2023 | ₹61.87 | ₹54.91 | ₹5.03 |
Dec 2023 | ₹62.18 | ₹51.03 | ₹7.75 |
Quest Laboratories IPO Valuation – FY2023
Check Quest Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
Earning Per Share (EPS): | ₹4.66 per Equity Share |
Price/Earning P/E Ratio: | NA |
Return on Net Worth (RoNW): | 33.47% |
Net Asset Value (NAV): | ₹13.93 per Equity Share |
Peer Group
- Beta Drugs Limited
- Alpa Laboratories Limited
- Zenith Drugs Limited
Company Promoters
- Mr. Anil Kumar Sabarwal
- Ms. Tejaswini Sabarwal
Quest Laboratories IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
Quest Laboratories IPO Allotment Status
Check Quest Laboratories IPO allotment status on Bigshare website URL. Click Here
Quest Laboratories IPO Lead Managers aka Merchant Bankers
- Shreni Shares Limited
Company Address
Quest Laboratories Limited
Plot No. 45, Sector III
Pithampur Industrial Area, Pithampur
Dhar – 454775,
Phone: 07292292374
Email: investors@questlabltd.com
Website: https://www.questlabltd.com/